首页> 外文期刊>Journal of biochemical and molecular toxicology >Overexpression of RYBP inhibits proliferation, invasion, and chemoresistance to cisplatin in anaplastic thyroid cancer cells via the EGFR pathway
【24h】

Overexpression of RYBP inhibits proliferation, invasion, and chemoresistance to cisplatin in anaplastic thyroid cancer cells via the EGFR pathway

机译:RyBP的过度表达抑制通过EGFR途径在促进型甲状腺癌细胞中的顺铂的增殖,侵袭和化学抑制剂

获取原文
获取原文并翻译 | 示例
           

摘要

Ring1 and YY1 binding protein (RYBP), a new member of the polycomb group protein family, has been reported to play an important role in various biological processes. Recently, more and more studies have demonstrated an implication of RYBP in cancer development. However, the specific role of RYBP in anaplastic thyroid cancer (ATC) remains unknown. In this study, we investigated for the first time the expression pattern and biological functions of RYBP in ATC. We showed that RYBP was lowly expressed in ATC tissues and cell lines. We also found that overexpression of RYBP inhibited ATC cell proliferation, invasion, and cisplatin resistance. Furthermore, we observed that upregulation of RYBP decreased the phosphorylation of EGFR and ERK1/2 in ATC cells. Taken together, our data indicated that RYBP might be considered as a promising therapeutic target for the treatment of ATC.
机译:据报道,Ring1和YY1结合蛋白(RYBP)是多元组蛋白家族的新成员,在各种生物过程中发挥着重要作用。 最近,越来越多的研究表明RYBP在癌症发展中的含义。 然而,Rybp在血换甲状腺癌(ATC)中的特定作用仍然未知。 在这项研究中,我们研究了RYBP在ATC中的第一次表达模式和生物学功能。 我们表明RYBP在ATC组织和细胞系中略微表达。 我们还发现RYBP的过度表达抑制ATC细胞增殖,侵袭和顺铂抗性。 此外,我们观察到RyBP的上调降低了ATC细胞中EGFR和ERK1 / 2的磷酸化。 我们的数据占据了,我们的数据表明,RYBP可能被认为是治疗ATC的有希望的治疗目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号